Literature DB >> 31537264

From Proteomics to Therapeutics: Sex Differences in Cardiovascular Disease Risk Do Matter.

Shweta R Motiwala1.   

Abstract

Entities:  

Keywords:  biomarkers; cardiovascular disease; female; sex

Mesh：

Substances：

Year:  2019        PMID： 31537264     DOI： 10.1016/j.jacc.2019.08.011

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Single-Cell RNA Sequencing and Quantitative Proteomics Analysis Elucidate Marker Genes and Molecular Mechanisms in Hypoplastic Left Heart Patients With Heart Failure.

Authors:  Li Ma; Na Zhou; Rongjun Zou; Wanting Shi; Yuanyuan Luo; Na Du; Jing Zhong; Xiaodong Zhao; Xinxin Chen; Huimin Xia; Yueheng Wu
Journal:  Front Cell Dev Biol       Date:  2021-02-25

2.  Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality.

Authors:  Agne Laucyte-Cibulskiene; Liam J Ward; Valeria Raparelli; Karolina Kublickiene; Thomas Ebert; Giulia Tosti; Claudia Tucci; Leah Hernandez; Alexandra Kautzky-Willer; Maria-Trinidad Herrero; Colleen M Norris; Louise Pilote; Magnus Söderberg; Torkel B Brismar; Jonaz Ripsweden; Peter Stenvinkel
Journal:  Biol Sex Differ       Date:  2021-09-15       Impact factor: 5.027
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.